Not to be confused with the theme park attraction Disney's Hollywood Studios. Eisner, Disney's then-chief, intended Hollywood Pictures to be a full-fledged studio, like Touchstone, but in its later ...

(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...

Satellite images and on-the-ground photos show the scale of destruction caused by the floods. A selection of the week's best photos from across the African continent and beyond. A picture of a fox ...

(AP Photo/Anjum Naveed) The Sydney Opera House sails show photos of Britain’s King Charles and Queen camilla soon after their arrival in Sydney, Australia, Friday, Oct. 18, 2024. (AP Photo/Mark Baker) ...

Looking back at the career of the Grateful Dead bassist, starting with when the band was clean cut and called the Warlocks. Looking back at the career of the Grateful Dead bassist, starting with ...

We've rounded up the best cameras for photos and videos. Research ahead of Black Friday and use one this month to capture the Northern Lights or the Taurid meteor shower. The best cameras are a ...

Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

Sanofi expects a low single-digit decline in flu shot sales due to the soft vaccination rate. Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company ...

(Reuters) - French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than-anticipated start of the vaccination season.

Sanofi reported a 25% boost in sales for its vaccines division during the third quarter, helped by earlier-than-anticipated orders of its flu shots as well as rising revenue from Beyfortus, its RSV ...

Leerink Partners analyst David Risinger in a Friday note to investors said Sanofi expects Q4 Beyfortus sales similar to Q3. Sanofi released its third-quarter earnings report on Friday, beating ...